Amy Schacterle

Amy Schacterle

Chief Operating Officer at SAGE THERAPEUTICS, INC.

Health Technology

Consumer Services

Amy Schacterle active positions

Companies	Position	Start	End
SAGE THERAPEUTICS, INC.	Chief Operating Officer	31/03/2020	-
	Chief Tech/Sci/R&D Officer	31/03/2020	-
	General Counsel	12/02/2015	31/03/2020

Career history of Amy Schacterle

Former positions of Amy Schacterle

Companies	Position	Start	End
Sumitomo Pharma America, Inc. Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Sumitomo Pharma America, Inc. operates as a biopharmaceutical company that develops pharmaceutical products. Its products include Aptiom (eslicarbazepine acetate) tablets, Latuda (lurasidone HCl) tablets, Lunesta (eszopiclone) tablets, Xopenex (levalbuterol HCl) Inhalation Solution, Xopenex HFA (levalbuterol tartrate) Inhalation Aerosol, Brovana (arformoterol tartrate) Inhalation Solution, Omnaris (ciclesonide) Nasal Spray, Alvesco (ciclesonide) Inhalation Aerosol, and Zetonna (ciclesonide) Nasal Aerosol. The company was founded in 2010 and is headquartered in Marlborough, MA.	General Counsel	31/12/2003	31/12/2013

Training of Amy Schacterle

Rensselaer Polytechnic Institute	Undergraduate Degree
University of Virginia	Doctorate Degree

Statistics

International

United States

5

Operational

General Counsel	2
Chief Operating Officer	1
Chief Tech/Sci/R&D Officer	1

Sectoral

Health Technology	3
Consumer Services	3

Positions held

Active

Inactive

Listed companies

Private companies

Linked companies

Listed companies	1
SAGE THERAPEUTICS, INC.	Health Technology

Private companies

1

Health Technology

See company connections

All transcripts on over 9000 companies, on the day they post their earnings!

Unlock them now!

fermer